Shilov EM - Search Results

1

[Complement System Abnormalities in Patients with Atypical Hemolytic Uremic Syndrome and Catastrophic Antiphospholipid Syndrome].

Demyanova KA, Kozlovskaya NL, Bobrova LA, Kozlov LV, Andina SS, Yurova VA, Kuchieva AM, Roshchupkina SV, Shilov EM. Demyanova KA, et al. Among authors: shilov em. Vestn Ross Akad Med Nauk. 2017;72(1):42-52. doi: 10.15690/vramn769. Vestn Ross Akad Med Nauk. 2017. PMID: 29308852 Russian.

2

[Alterations of the complement system in patients with catastrophic antiphospholipid syndrome].

Dem'ianova KA, Kozlovskaia NL, Shilov EM, Bobrova LA, Kozlov LV, Sorokin IuD, Roshchupkina SV, Nikiforova NV, Dobrosmyslov IA, Romanova MD. Dem'ianova KA, et al. Among authors: shilov em. Ter Arkh. 2014;86(6):30-7. Ter Arkh. 2014. PMID: 25095653 Russian.

3

[Cardiac involvement in thrombotic microangiopathies].

Tuter DS, Kopylov FY, Kozlovskaya NL, Demyanova KA, Shchekochikhin DY, Shilov EM, Syrkin AL. Tuter DS, et al. Among authors: shilov em. Ter Arkh. 2015;87(9):17-25. doi: 10.17116/terarkh201587917-25. Ter Arkh. 2015. PMID: 26591548 Russian.

4

[Hyponatremia: A clinical approach].

Shchekochikhin DY, Kozlovskaya NL, Kopylov FY, Syrkin AL, Shilov EM. Shchekochikhin DY, et al. Among authors: shilov em. Ter Arkh. 2017;89(8):134-140. doi: 10.17116/terarkh2017898134-140. Ter Arkh. 2017. PMID: 28914864 Review. Russian.

5

Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy.

Novikov P, Kozlovskaya N, Moiseev S, Shilov E, Bobkova I, Schreiber A, Tsvetkov D, Gollasch M, Mah N, El Amrani K, Kurtz A. Novikov P, et al. Biomed Hub. 2016 Dec 13;1(3):1-11. doi: 10.1159/000453106. eCollection 2016 Sep-Dec. Biomed Hub. 2016. PMID: 31988889 Free PMC article. Review.

6

[Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].

Serikova SIu, Kozlovskaia NL, Shilov EM. Serikova SIu, et al. Among authors: shilov em. Ter Arkh. 2008;80(6):52-8. Ter Arkh. 2008. PMID: 18655477 Russian.

7

[Clinical manifestations of APS-nephropathy in primary antiphospholipid syndrome].

Shilov EM, Kozlovskaia NL, Meteleva NA, Kozlovskaia LV, Varshavskiĭ VA, Miroshnichenko NG, Blokhina GV, Serova AG, Nesterova SG, Smolianitskiĭ AIa. Shilov EM, et al. Ter Arkh. 2003;75(6):22-7. Ter Arkh. 2003. PMID: 12920954 Russian.

8

[Low-molecular heparins in the treatment of APS-nephropathy in primary and secondary antiphospholipid syndrome].

Kozlovskaia NL, Shakhnova EA, Kushnir VV, Shilov EM. Kozlovskaia NL, et al. Among authors: shilov em. Ter Arkh. 2004;76(9):35-40. Ter Arkh. 2004. PMID: 15532374 Russian.

9

[Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].

Kozlovskaia NL, Shilov EM, Meteleva NA, Varshavskiĭ VA, Miroshnichenko NG, Samokishina NA, Serova AG, Nesterova SG. Kozlovskaia NL, et al. Among authors: shilov em. Ter Arkh. 2006;78(5):21-31. Ter Arkh. 2006. PMID: 16889045 Russian.

10

[Clinicomorphological features of nephropathy in primary and secondary antiphospholipid syndrome].

Kozlovskaia NL, Shilov EM, Meteleva NA, Varshavskiĭ VA, Kushnir VV, Shakhnova EA, Miroshnichenko NG, Serova AG, Nesterova SG. Kozlovskaia NL, et al. Among authors: shilov em. Ter Arkh. 2007;79(6):16-25. Ter Arkh. 2007. PMID: 17684961 Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page